Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871

Detalles Bibliográficos
Autores principales: Meagher, Craig, Cruikshank, William, Delovitch, Terry L.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Online Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028377/
http://dx.doi.org/10.2337/db10-1620
_version_ 1782197175472619520
author Meagher, Craig
Cruikshank, William
Delovitch, Terry L.
author_facet Meagher, Craig
Cruikshank, William
Delovitch, Terry L.
author_sort Meagher, Craig
collection PubMed
description
format Text
id pubmed-3028377
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-30283772012-02-01 Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871 Meagher, Craig Cruikshank, William Delovitch, Terry L. Diabetes Online Letters to the Editor American Diabetes Association 2011-02 2011-01-21 /pmc/articles/PMC3028377/ http://dx.doi.org/10.2337/db10-1620 Text en © 2011 by the American Diabetes Association.
spellingShingle Online Letters to the Editor
Meagher, Craig
Cruikshank, William
Delovitch, Terry L.
Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_full Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_fullStr Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_full_unstemmed Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_short Response to Comment on: Meagher et al. Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes 2010;59:2862–2871
title_sort response to comment on: meagher et al. neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a ccl4-dependent mechanism. diabetes 2010;59:2862–2871
topic Online Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028377/
http://dx.doi.org/10.2337/db10-1620
work_keys_str_mv AT meaghercraig responsetocommentonmeagheretalneutralizationofinterleukin16protectsnonobesediabeticmicefromautoimmunetype1diabetesbyaccl4dependentmechanismdiabetes20105928622871
AT cruikshankwilliam responsetocommentonmeagheretalneutralizationofinterleukin16protectsnonobesediabeticmicefromautoimmunetype1diabetesbyaccl4dependentmechanismdiabetes20105928622871
AT delovitchterryl responsetocommentonmeagheretalneutralizationofinterleukin16protectsnonobesediabeticmicefromautoimmunetype1diabetesbyaccl4dependentmechanismdiabetes20105928622871

Ejemplares similares